Navigation Links
Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on,Targeted, Systemic Delivery of siRNA

Calando Pharmaceuticals Inc.

Calando Pharmaceuticals Inc. (www.calandopharma.com), a majority owned subsidiary of Arrowhead Research Corporation (NASDAQ: ARWR), is using its proprietary technologies in targeted polymeric delivery systems and siRNA design to design and create new, targeted siRNA therapeutics. The company is pursuing this goal through its internal research and development and also through collaborations and partnerships with pharmaceutical and biotechnology companies.

Calando Technology

Calando's cyclodextrin-containing polymers form the foundation for its two-part siRNA delivery system. The first component is a linear, cyclodextrin-containing polycation that, when mixed with small interfering RNA (siRNA), binds to the anionic "backbone" of the siRNA. The polymer and siRNA self-assemble into nanoparticles of approximately 50-80 nm diameter that fully protect the siRNA from nuclease degradation in serum. The siRNA delivery system has been designed to allow for intravenous injection. Upon delivery to the target cell, the targeting ligand binds to membrane receptors on the cell surface and the RNA-containing nanoparticle is taken into the cell by endocytosis. There, chemistry built into the polymer functions to unpackage the siRNA from the delivery vehicle. In addition to targeting tumors, the targeting of liver cells has also been accomplished in vivo.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the recent economic slowdown affecting technology companies, the fu
'"/>




Page: 1 2 3

Related medicine technology :

1. Arrowhead Subsidiary, Insert, Publishes Interim Phase I Data from Human Clinical Trials for New Cancer Drug
2. Arrowhead Subsidiaries Insert & Calando Present Data on Cyclosert Drug Delivery System at AACR Meeting
3. Arrowhead Subsidiary Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate
4. CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal
5. Calando Pharmaceuticals Announces Preclinical Efficacy and Safety Data of Targeted, Systemic Delivery of siRNA at AACR Annual Meeting
6. Calando Pharmaceuticals Publishes Study Showing Anti-Cancer Effect with Lead RNAi Candidate
7. Calando Pharmaceuticals Publishes the First Non-Human Primate Study on Targeted, Systemic Delivery of siRNA in National Academy of Sciences Journal
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference

Post Your Comments:
(Date:11/6/2009)... SCOLR Pharma, Inc. (Ame... three and nine months ended September 30, 2009. ... and CEO, said, "We continue to advance discussion...lation. Several potential partners have committed ...nal resources as they evaluate the potential comme...
(Date:11/6/2009)...ewswire/ -- Trius Therapeutics, Inc. announced tod...orm S-1 with the U.S. Securities and Exchange Comm... offering of shares of its common stock. All share...ill be offered by the Company. ,, Credit Suisse...ng manager, Piper Jaffray & Co. is acting as c...
(Date:11/6/2009)...swire-FirstCall/ -- Caraco Pharmaceutical Laborato...ac tromethamine ophthalmic solution, 0.5% followin...istration (FDA) for Sun Pharma,s Abbreviated New D...hthalmic solution on the first day following paten...eutically equivalent to Acular® Ophthalmic So...
Breaking Medicine Technology:SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 2SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 3SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 4SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 5SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 6SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 7SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 8SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results 9Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2Press Ganey Announces Opening of Boston Office 50948 1Press Ganey Announces Opening of Boston Office 50948 2Are Breast Cancer Patients Being Kept In The Dark 3F 50942 1Are Breast Cancer Patients Being Kept In The Dark 3F 50942 2Obama Administration Advances Long Term Services and Supports in Health Care Reform 50938 1Obama Administration Advances Long Term Services and Supports in Health Care Reform 50938 2
...MonoSol Rx, a specialty,pharmaceutical company lev...o develop thin film pharmaceutical products, today...ment for its thin film formulation of,escitalopram....,Escitalopram oxalate is indicated for depression... under the brand name Lexapro(R). Lexapro,generate...
...ffective Drug for Rare Genetic Disorder in,Childre...,a drug to achieve normal levels of blood sugar in... high insulin levels. If this approach,succeeds in...r children,with congenital hyperinsulinism, a rare...ich insulin levels become dangerously high., "The...
Other Medicine Technology:MonoSol Rx Completes Thin Film Escitalopram Oxalate Pilot Product Development 2MonoSol Rx Completes Thin Film Escitalopram Oxalate Pilot Product Development 3Treatment Corrects Severe Insulin Imbalance in Animal Studies 2Treatment Corrects Severe Insulin Imbalance in Animal Studies 3
(Date:11/7/2009)...wire/ -- With the final House vote on healthcare r...he entire bill hostage to further their antiaborti... beyond the status quo restrictions on abortion th...In an outrageous amendment, which is expected to b...mocrats are demanding explicit and unequivocal exc...
(Date:11/7/2009)...wire/ -- Speaker Nancy Pelosi and Democratic leade...ing a Democratic Whip meeting with President Obama...,s opening remarks: ,, "Thank you very much, M...eceive the President of the United States on this ...nd making progress for the American people. ,...
(Date:11/7/2009)... rebel, expert says , , SATURDAY, Nov. 7 (... badly if their parents expect them to, a new U.S....simply being realistic might actually contribute t... psychology professor at Wake Forest University an...s release. "Negative expectations on the part of b...
(Date:11/7/2009)...nomic climate, many Americans are monitoring their...n what that they consider to be absolutely essenti...eves that it’s very important for overweight...mprove their health, and he is trying to make weig...gh economy by offering reasonable prices and multi...
(Date:11/6/2009)... 6 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. ...t will report financial results for the third quar...day, November 9, 2009. Cardiome will hold a teleco...m Pacific) on that day to discuss the results. ,, ...-7806 or 888-789-9572 and reference conference 234...
Breaking Medicine News(10 mins):Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 3Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3
...t will pilot a unique, distributed, electronic,res...etermine which,treatments work best for specific d...Joseph H. Kanter,Family Foundation and the eHealth... will create a model for using,electronic health i...
...11 Ortho Organizers, Inc., a,global leading manuf...cation programs, announced today that it has opene...thodontic Laboratory is located in Ortho,Organizer...ws the Company to further its,commitment to cultiv...
...jected to Increase 600% Among Latinos by 2050, WA...,teamed up with Celebra La Vida Con Salud, the lar...to build awareness among U.S. Latinos about the,im...ently 200,000 Latinos in America with Alzheimer,s ...
...ve childhood brain tumor known as medulloblastoma ...malignant when acted on by a known mutant, cancer-... Cancer Institute and the University of California...arly stem cells as well as more mature cells. Prev...
... Medexsupply, ( http://www.medexsupply.com ) a ...ts and equipment announced the release of the ADC ... health market. The company will donate a portion ...day, Medexsupply, a national leader in the supply ...
... The health of people who never marry is improving..., according to new research that suggests the prac... be misguided. , Hui Liu, assistant professor of ...alth more so for men than for women. , "Married p...
Other Medicine News:Health News:Joseph H. Kanter Family Foundation and eHealth Initiative Foundation Launch Partnership to Conduct Research on Health Outcomes, Comparative Effectiveness 2Health News:Joseph H. Kanter Family Foundation and eHealth Initiative Foundation Launch Partnership to Conduct Research on Health Outcomes, Comparative Effectiveness 3Health News:Joseph H. Kanter Family Foundation and eHealth Initiative Foundation Launch Partnership to Conduct Research on Health Outcomes, Comparative Effectiveness 4Health News:Joseph H. Kanter Family Foundation and eHealth Initiative Foundation Launch Partnership to Conduct Research on Health Outcomes, Comparative Effectiveness 5Health News:Ortho Organizers(R) Opens a Full-Service Orthodontic Laboratory 2Health News:Alzheimer's Association Joins Celebra Hispanic Health Education Campaign to Build Awareness About Impact of Alzheimer's and Resources Available for Latinos 2Health News:Alzheimer's Association Joins Celebra Hispanic Health Education Campaign to Build Awareness About Impact of Alzheimer's and Resources Available for Latinos 3Health News:Childhood brain tumor traced to normal stem cells gone bad 2Health News:Childhood brain tumor traced to normal stem cells gone bad 3Health News:MedexSupply Announces the Release of the ADC Limited Edition Pink Ribbon Stethoscope, With Proceeds Being Donated to Breast Cancer Research 2Health News:MedexSupply Announces the Release of the ADC Limited Edition Pink Ribbon Stethoscope, With Proceeds Being Donated to Breast Cancer Research 3Health News:MedexSupply Announces the Release of the ADC Limited Edition Pink Ribbon Stethoscope, With Proceeds Being Donated to Breast Cancer Research 4Health News:Health and marriage: The times they are a changin' 2
... The Research Family includes fixed-volume, adjust...e electronic Eppendorf Research pro Pipette. Desig...act, high-performance pipettes have earned a world...or use with original Eppendorf pipette tips, they ...
Ovation BioNatural Pipette, two-stroke, fixed volume, 10L
Pipetman F10
Finnpipette Fixed Volume, 10ul
Medicine Products: